Testing irony: Explosion in new COVID-19 infections could speed up vaccine development

https specials images forbesimg com imageserve x
Credit: Getty Images

More than 20 coronavirus vaccines are in human testing, according to the World Health Organization. So far, small, early studies of most advanced vaccines found they were generally safe and triggered immune responses but weren’t designed to prove whether they actually protected people.

A series of large, final-stage trials are getting under way that, for the first time, will decisively test whether coronavirus vaccines prevent or reduce risk of Covid-19, including 30,000-person studies for vaccines from Moderna Inc. and from Pfizer Inc. and its partner, BioNTech SE, slated to start by the end of July.

The new studies will be “event-driven,” which means researchers expect to learn whether the vaccines are working once a certain number of study subjects come down with Covid-19, the disease caused by the new coronavirus.

Related article:  Reality dawning: COVID will alter how we live for years or decades to come

Initially researchers thought it could take many months to accrue enough Covid-19 cases among study subjects to yield answers because lockdown measures slowed the spread of the virus and the hot summer weather threatened to slow it further.

ADVERTISEMENT
Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

But Covid-19 counts are rising in countries such as Brazil, Peru and South Africa. Cases have also flared in parts of the U.S. since mid-June, particularly in states such as California, Texas and Florida.

“Because of the bad situation in the U.S., we might actually get a very quick readout for vaccines,” possibly in October, [said Moderna’s Stephane Bancel.]

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend